MDS Pharma Services Names Rudy Howard Chief Financial Officer
07 Januar 2009 - 2:00PM
PR Newswire (US)
KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ -- MDS Pharma
Services, a leading provider of innovative drug discovery and
development solutions, today announced the appointment of Rudy
Howard as Senior Vice-President and Chief Financial Officer. Mr.
Howard has extensive experience as a senior financial executive in
the pharmaceutical and contract research organization (CRO)
industry sectors, including six years as CFO at Pharmaceutical
Product Development, Inc. He joins MDS Pharma Services from his
private consulting practice where he offered business and financial
consulting services, including merger and acquisition services, for
clients across a variety of industries, including pharmaceutical
and biotechnology. "We are delighted to add someone with Rudy's
breadth and depth of skills and expertise to our leadership team at
MDS Pharma Services," said MDS Pharma Services President David
Spaight. "His impressive portfolio of financial, business
development and change management capabilities in the
pharmaceutical and contract research industries makes him an
excellent choice to lead the MDS Pharma Services finance
organization at this time." Before founding his consulting
practice, Mr. Howard was CFO at Peopleclick Inc., a human resources
software-development company. Previously, he was a Partner at
PricewaterhouseCoopers, where his specialization included financial
services, high technology, pharmaceuticals and manufacturing. He
began his career in public accounting with Deloitte and Touche LLP.
About MDS Pharma Services MDS Pharma Services is committed to
delivering quality service on-time. We offer a full spectrum of
resources to meet the drug-discovery and development needs of the
pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, we apply
advanced scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND
research, early clinical research (bioequivalence, phases I-IIa)
and bioanalysis through to global clinical development (phases
IIb-IV), central lab and centralized cardiac services. For more
information, visit our website at http://www.mdsps.com/. MDS Pharma
Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a
global life-sciences company that provides market-leading products
and services that our customers need for the development of drugs
and diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 5,000 highly skilled people in 29 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Pharma Services CONTACT: Media:
Charlene McGrady, (610) 239-7900, ext. 231, ; Investors: Kim Lee,
(416) 213-4721,
Copyright